Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05826782
Other study ID # 344119007
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2023
Est. completion date February 25, 2024

Study information

Verified date November 2023
Source Kocaeli University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Infertility is defined as the inability to become pregnant despite 12 months of regular and unprotected intercourse. Male factors include defects in sperm concentration, morphology and motility, among which low sperm motility (asthenozoospermia) is one of the most common types of male infertility and affects approximately 40% of all cases. It has become clear that protein defects in spermatozoa and semen can cause fertilization failure by affecting sperm motility, and it is necessary to define proteins and related pathways precisely because they have an important role in the treatment phase. Increasing evidence shows that free oxygen radicals that occur as a result of oxidative stress (OS) play a very important role in the etiology of male infertility. A systematic review including 29 studies (19 randomized clinical trials and 10 prospective studies) examined the effect of antioxidant food supplementation and reported a positive effect on baseline semen parameters, advanced sperm function, outcomes of assisted reproductive therapy, and live birth rate. Conversely, few studies have failed to confirm any positive effect of antioxidant therapy and even report a negative effect on male fertility. Therefore, there is no clear consensus on the clinical efficacy of antioxidant therapy yet. Since the pathogenesis has not yet been clearly demonstrated, treatments are not based on evidence, but based on clinical experience. Our aim was to randomly divide infertile male patients who applied to our clinic with the complaint of infertility and found asthenozoospermia (restricted sperm motility) in their semen analysis into two arms and examine the effects of antioxidant food supplementation on sperm motility and proteomic structure with a placebo-comparative, prospective, double-blind study (LC-MS/MS). analysis) is to reveal the metabolic pathways that may lead to restriction of movement. The effect of antioxidant food support on sperm parameters and free oxygen radical levels in the control spermiogram after 3 (three) months of treatment to be given to the patients will be measured by ELISA method and compared with pre-treatment values.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date February 25, 2024
Est. primary completion date January 30, 2024
Accepts healthy volunteers No
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: 1. Being in the age range of 20-40 2. Be infertile ( 12 months intercourse without any contraception) 3. Due to infertility, you should apply to us and have a spermiogram detection of asthenozoospermia 4. Patients whose spouses have normal gynecological examinations 5. Patients with normal physical examinations 6. Patients with normal hormonal values (FSH, LH,PRL,Testosterone,Estrogen) - Exclusion Criteria: 1. previous treatment for infertility 2. Previously due to infertility or for any reason take antioxidant food supplements 3. Surgery or physical examination due to varicocele detection of varicocele 4. Detection of endocrine disorder (Defect in serum blends) 5. Smokers and alcohol addiction 6. Detection of infection in the genital tract 7. Having a chronic illness -

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Proxeed Plus 2*1 A arm
Proxeed plus 2 x daily sachets (2*1) three mounths
Placebo
Placebo 2 x daily sachets (2*1) three mounths

Locations

Country Name City State
Turkey Naci Burak Çinar Kocaeli Izmit

Sponsors (2)

Lead Sponsor Collaborator
Kocaeli University ECZACIBASI

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary sperm motility (%) semen analysis (microscopic analysis) 12 weeks
Secondary Proteomics analysis Water for chromatography (LC-MS Grade) 8 weeks
Secondary oxidative stress ROS (Human SOD1(Superoxide Dismutase 1, Soluble) ELISA) 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05506722 - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity N/A
Completed NCT04291495 - Evaluation of the Effects of Semen Incubation With ANDROSITOL®DGN on Sperm Motility and Mitochondrial Membrane Potential N/A
Completed NCT01954498 - Effect of Walnuts on Sperm Parameters and Male Fertility N/A
Not yet recruiting NCT05792813 - Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility Early Phase 1
Recruiting NCT01856361 - Ramipril for the Treatment of Oligospermia N/A
Completed NCT02217189 - Study of the Effect of Oral Zinc Supplementation on Superoxide Radical Scavengers Phase 2
Completed NCT01684059 - Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway N/A
Completed NCT01612403 - Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen N/A
Completed NCT02985905 - The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index Phase 2
Recruiting NCT03183999 - Effect of Fermented Ginseng (GINST) on Sperm Motility N/A
Completed NCT03463005 - The Effect of Royal Vaginal Gel Compared to IUI Technique on Fertility Rate of Women With Low-fertility Husbands N/A
Recruiting NCT05628987 - The Association of Gut Microbiota and Spermatogenic Dysfunction
Completed NCT01846325 - The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia Phase 2/Phase 3
Completed NCT01828710 - Myo-inositol on Human Semen Parameters N/A
Recruiting NCT05328999 - Fertility and the Microbiome
Not yet recruiting NCT05436080 - Epididymal U.S Findings in Asthenozoospermic &Correlation With L.Carnitine Level